Published in J Am Coll Cardiol on May 05, 2004
Beta-blocker use is associated with lower stroke and death after carotid artery stenting. J Vasc Surg (2015) 1.39
Hyperperfusion syndrome after carotid stent-supported angioplasty in patients with autonomic dysfunction. J Korean Neurosurg Soc (2012) 0.94
Carotid Stenting without Angioplasty and without Protection: The Advantages of a Less Invasive Procedure. Interv Neuroradiol (2008) 0.92
Treatment and outcome of intracranial hemorrhage after carotid artery stenting. A ten year single center experience. Interv Neuroradiol (2009) 0.82
Hyperperfusion Syndrome after Carotid Artery Stenting. Med J Armed Forces India (2013) 0.82
The role of perfusion computed tomography in the prediction of cerebral hyperperfusion syndrome. PLoS One (2011) 0.81
Intracranial stenting in atherosclerotic disease-recent results and challenges to face. Neuroradiology (2010) 0.81
Clinical Presentation, Imaging, and Management of Complications due to Neurointerventional Procedures. Semin Intervent Radiol (2015) 0.80
Simultaneous bilateral carotid stenting in a series of 9 patients: a single-center experience with review of literature. J Clin Imaging Sci (2012) 0.80
Dilation of the Internal Carotid Artery at the Entrance to the Carotid Canal following Carotid Artery Stenting Predicts Postprocedural Hyperperfusion. Interv Neurol (2013) 0.80
Rapid formation of cerebral microbleeds after carotid artery stenting. Cerebrovasc Dis Extra (2012) 0.80
Antiplatelet therapy for carotid artery stenting. Interv Neurol (2013) 0.79
Delayed cerebral hyperperfusion syndrome three weeks after carotid artery stenting presenting as status epilepticus. J Korean Neurosurg Soc (2014) 0.79
Intracerebral Hemorrhage after Carotid Artery Stenting without Evidence of Hyperperfusion in Positron Emission Tomography. Interv Neuroradiol (2007) 0.78
Cerebral Blood Flow Change Before and After Carotid Angioplasty and Stenting (CAS) in Cases with Contralateral Carotid Artery Occlusion. Interv Neuroradiol (2006) 0.77
Reversible cerebral hyperperfusion syndrome after stenting of the carotid artery - two case reports. Clin Res Cardiol (2006) 0.77
Simultaneous Bilateral Carotid Stenting under the Circumstance of Neuroprotection Device. A Retrospective Analysis. Interv Neuroradiol (2006) 0.77
Long-term outcome after angioplasty of symptomatic internal carotid artery stenosis with and without stent. Neuroradiology (2007) 0.77
Treatment of acute ischemic stroke: beyond thrombolysis and supportive care. Neurotherapeutics (2011) 0.76
Venous reddening as a possible sign of hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: case report. Neurol Med Chir (Tokyo) (2014) 0.75
Carotid stenting for atherothrombosis. Heart (2007) 0.75
Intraprocedural detection of cerebral hyperperfusion by flat detector computed tomography in the evaluation of cerebral blood volume during carotid artery stenting. A case report. Interv Neuroradiol (2014) 0.75
Simultaneous Bilateral Carotid Stenting for Symptomatic Bilateral High-Grade Carotid Stenosis: A Retrospective Clinical Investigation. Med Sci Monit (2016) 0.75
A case of cerebral hyperperfusion following spontaneous recanalization of occluded middle cerebral artery: Reperfusion injury or true cerebral hyperperfusion syndrome? Medicine (Baltimore) (2017) 0.75
Intraoperative dexmedetomidine and postoperative cerebral hyperperfusion syndrome in patients who underwent superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: A retrospective observational study. Medicine (Baltimore) (2016) 0.75
Percutaneous transluminal angioplasty and stenting for chronic total occlusion of intracranial carotid artery: a case report. Interv Neuroradiol (2006) 0.75
Using Flat-Panel Perfusion Imaging to Measure Cerebral Hemodynamics: A Pilot Feasibility Study in Patients With Carotid Stenosis. Medicine (Baltimore) (2016) 0.75
Comparison of outcomes and utilization of extracranial-intracranial bypass versus intracranial stenting for intracranial stenosis. Surg Neurol Int (2014) 0.75
Thalamic hemorrhage six days after carotid artery stenting. Ann Saudi Med (2011) 0.75
Cerebral Hyperperfusion Syndrome following Protected Carotid Artery Stenting. Case Rep Vasc Med (2013) 0.75
Staged carotid artery angioplasty and stenting for patients with high-grade carotid stenosis with high risk of developing hyperperfusion injury: a retrospective analysis of 44 cases. Stroke Vasc Neurol (2016) 0.75
Intracerebral Hemorrhage Caused by Cerebral Hyperperfusion after Superficial Temporal Artery to Middle Cerebral Artery Bypass for Atherosclerotic Occlusive Cerebrovascular Disease. NMC Case Rep J (2016) 0.75
Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med (2008) 4.72
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet (2011) 4.59
A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke (2008) 1.66
The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention. Stroke (2006) 1.64
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke (2002) 1.62
Feasibility of simultaneous bilateral carotid artery stenting. Catheter Cardiovasc Interv (2004) 1.50
Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). Am J Cardiol (2005) 1.49
Endovascular management of spontaneous carotid artery dissection. J Vasc Surg (2005) 1.48
Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial. Catheter Cardiovasc Interv (2011) 1.48
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting. J Am Coll Cardiol (2013) 1.48
Effect of chronic kidney disease on outcomes after carotid artery stenting. Am J Cardiol (2004) 1.47
Cutting balloon angioplasty to treat carotid in-stent restenosis. J Invasive Cardiol (2004) 1.42
Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty alone. J Invasive Cardiol (2003) 1.41
Carotid stenting vs surgery: parsing the risk of stroke and MI. Cleve Clin J Med (2010) 1.41
Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center. Am J Cardiol (2005) 1.39
The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv (2007) 1.38
Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke (2005) 1.25
Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke (2005) 1.24
CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail (2011) 1.24
Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv (2006) 1.20
Rate, predictors, and consequences of hemodynamic depression after carotid artery stenting. J Am Coll Cardiol (2006) 1.17
EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke (2014) 1.13
The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv (2007) 1.12
Endovascular treatment of carotid artery aneurysms with stent grafts. J Invasive Cardiol (2002) 1.02
Slow-flow phenomenon during carotid artery intervention with embolic protection devices: predictors and clinical outcome. J Am Coll Cardiol (2005) 0.98
Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J (2002) 0.98
Endovascular repair of carotid artery aneurysm with Jostent covered stent: initial experience and one-year result. Catheter Cardiovasc Interv (2004) 0.95
Time course of early postadmission hematoma expansion in spontaneous intracerebral hemorrhage. Stroke (2014) 0.92
Percutaneous treatment for pacemaker-associated superior vena cava syndrome. Pacing Clin Electrophysiol (2002) 0.91
The management of renal artery atherosclerosis for renal salvage: does stenting help? J Vasc Surg (2007) 0.91
Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia. Stroke (2004) 0.91
Utility of IVUS-guided transaccess catheter in the treatment of long chronic total occlusion of the superficial femoral artery. Catheter Cardiovasc Interv (2004) 0.90
The CAPTURE registry: analysis of strokes resulting from carotid artery stenting in the post approval setting: timing, location, severity, and type. Ann Surg (2007) 0.90
Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J Neuroimaging (2006) 0.90
Inferior vena cava thrombus associated with intravascular cooling catheter. Resuscitation (2010) 0.88
Carotid artery stenting versus surgery: adequate comparisons? Lancet Neurol (2010) 0.87
Technical refinements and drawbacks of a surface cooling technique for the treatment of severe acute ischemic stroke. Neurocrit Care (2004) 0.87
Hypothermia for acute ischemic stroke: not just another neuroprotectant. Neurologist (2003) 0.86
Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv (2007) 0.86
Assessing the current role of platelet function testing. Clin Cardiol (2008) 0.86
Carotid stenting. Circulation (2006) 0.86
Intracranial angioplasty and stenting in the awake patient. J Neuroimaging (2006) 0.86
Evaluating the optimal activated clotting time during carotid artery stenting. Am J Cardiol (2006) 0.86
Posterior scleritis presenting as unilateral secondary angle-closure glaucoma. Indian J Ophthalmol (2004) 0.85
Health-related quality of life following carotid stenting versus endarterectomy: results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at HIgh Risk for Endarterectomy) trial. JACC Cardiovasc Interv (2010) 0.83
Therapeutic hypothermia for stroke: do new outfits change an old friend? Expert Rev Neurother (2005) 0.82
The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention. Clin Cardiol (2008) 0.81
Severe bilateral carotid stenosis: the impact of ipsilateral stenting on Doppler-defined contralateral stenosis. J Am Coll Cardiol (2004) 0.81
Carotid brachytherapy for in-stent restenosis. Catheter Cardiovasc Interv (2003) 0.80
New frontiers in interventional cardiology. Circulation (2005) 0.80
Feasibility trial of carotid stenting with and without an embolus protection device. J Endovasc Ther (2005) 0.80
The optimal treatment of carotid atherosclerosis: a 2008 update and literature review. Postgrad Med (2008) 0.79
Decompressive hemicraniectomy and durotomy for malignant middle cerebral artery infarction. Neurocrit Care (2008) 0.79
Predictive value of renal resistive index in percutaneous renal interventions for atherosclerotic renal artery stenosis. J Invasive Cardiol (2012) 0.79
Acute ischemic stroke: is there a role for hypothermia? Cleve Clin J Med (2002) 0.79
Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes. Clin Cardiol (2008) 0.79
Near infrared spectroscopy: finding utility in malignant hemispheric stroke. Neurocrit Care (2007) 0.78
Protecting the brain:how do we measure success? J Am Coll Cardiol (2003) 0.78
Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates. Am J Cardiol (2010) 0.78
Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting. Am J Cardiol (2005) 0.78
Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations. Am J Cardiol (2003) 0.77
Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention. Clin Cardiol (2008) 0.77
Safety of angioplasty and stenting without thrombolysis for the treatment of early ischemic stroke. J Neuroimaging (2008) 0.77
Antiplatelet therapy and platelet function testing. Clin Cardiol (2008) 0.77
E-learn computed tomographic angiography: a proposed educational tool for computed tomographic angiography in acute stroke. J Stroke Cerebrovasc Dis (2011) 0.77
Leukocyte count predicts microembolic Doppler signals during carotid stenting: a link between inflammation and embolization. Stroke (2005) 0.77
LA emptying fraction improves diagnosis of paroxysmal AF after cryptogenic ischemic stroke: results from the SURPRISE study. JACC Cardiovasc Imaging (2014) 0.77
Management of carotid artery disease in the high-risk patient with emphasis on the SAPPHIRE study. Curr Cardiol Rep (2007) 0.76
New insights into improving acute and long-term outcomes of carotid stenting. J Am Coll Cardiol (2006) 0.75
Assessing carotid revascularization should we abandon the neurological examination? JACC Cardiovasc Interv (2008) 0.75
Steeplechase in emergency medical care: cooling for cardiac arrest. Stroke (2006) 0.75
Functional occlusions of the carotid artery (string signs): to treat or not to treat? JACC Cardiovasc Interv (2010) 0.75
Superficial femoral artery occlusion: nitinol stents achieve flow and reduce the need for medications better than balloon angioplasty alone. J Invasive Cardiol (2004) 0.75
Symptomatic patients have similar outcomes compared with asymptomatic patients after carotid artery stenting with emboli protection. Am J Cardiol (2005) 0.75
OS 07-02 DIFFERENCES IN CIRCADIAN BLOOD PRESSURE VARIABILITY PATTERNS BETWEEN JAPANESE AND AMERICAN TREATMENT-RESISTANT HYPERTENSIVE POPULATIONS. J Hypertens (2016) 0.75
Investigating the mechanisms of hyporesponse to antiplatelet approaches. Clin Cardiol (2008) 0.75
GuardWire emboli protection device is associated with improved myocardial perfusion grade in saphenous vein graft intervention. Am Heart J (2004) 0.75
Carotid and peripheral intervention. J Invasive Cardiol (2004) 0.75
OS 07-02 DIFFERENCES IN CIRCADIAN BLOOD PRESSURE VARIABILITY PATTERNS BETWEEN JAPANESE AND AMERICAN TREATMENT-RESISTANT HYPERTENSIVE POPULATIONS. J Hypertens (2016) 0.75
Impact of diabetes mellitus on outcome of patients undergoing carotid artery stenting: insights from a single center registry. Catheter Cardiovasc Interv (2007) 0.75
Carotid stenting: the preferred management for carotid atherosclerosis? Indian Heart J (2008) 0.75
Image in Cardiology. Takayasu arteritis. Cardiol Rev (2002) 0.75
The role of stents in patients with carotid disease. Rev Cardiovasc Med (2003) 0.75
Impact of body mass index on outcome in patients undergoing carotid stenting. Am J Cardiol (2005) 0.75
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. Am J Cardiol (2003) 0.75
Use of PercuSurge GuardWire in native coronary arteries during acute myocardial infarction. J Invasive Cardiol (2004) 0.75
Effect of uncoated stenting versus balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on one-year event-free survival. Am J Cardiol (2003) 0.75